Human Genetics Market Size

Human Genetics Market size was valued at USD 32.4 billion in 2024 and is projected to reach USD 141.7 billion by the end of 2037, rising at a CAGR of 12% during the forecast period, i.e., 2025-2037. In 2025, the industry size of human genetics is assessed at USD 36.3 billion. 

Human genetics adoption is gaining traction due to advancements in gene sequencing technologies and an increasing need for personalized health solutions. Genetic testing permits early diagnosis, evaluation of risk, and treatment approaches for various life-threatening diseases, including some rare diseases and cancers. In July 2023, Novartis Espana partnered with DBGen Ocular Genomics to deliver genetic testing services for retinitis pigmentosa and Leber congenital amaurosis. Such collaborations highlight the demand for precision diagnostics in human genetics market. The engagement in such partnerships underlines the commitment of industry players to continuous innovation. This also opens up prospects for further growth, as governments and private investors are continually investing in genetic research and infrastructure.

Government support for genetic testing and personalized medicine creates more scope for players in the human genetics market. Many governments fund national genomic initiatives to study population-specific genetic information, which could help achieve better results in public health and ensure innovative healthcare. As governments continue to emphasize funding in healthcare research and develop policies that favor genetic advancements, the growth in the global human genetics industry is expected to be sustained.